2010

January 27 – 28, 2010
Outsourcing in Clinical Trials West Coast
Hyatt Hotel, Burlingame, CA

February 3-5, 2010
Central Labs West
Grand Hyatt, San Francisco, CA

2009

September 11 - 15, 2009
The American Society for Bone and Mineral Research 31st Annual Meeting (ASBMR)
Colorado Convention Center, Denver CO
Booth #: 708

September 10 - 13, 2009
Osteoarthritis Research Society International 2009 World Congress on Osteoarthritis (OARSI)
Hilton Montreal Bonaventure, Montreal Canada

October 16 - 21, 2009
American College of Rheumatology 2009 Annual Scientific Meeting (ACR)
ACR/ARHP Scientific Meeting '09
Pennsylvania Convention Center
Philadelphia, PA

2008

January 23-25, 2008
6th Annual Partnering with Central Labs, ECG, and Imaging Labs
Lake Buena Vista, FL

April 14-16, 2008
17th Annual Partnerships with CROs
Las Vegas, NV

May 6-7, 2008
CHI's Imaging and Clinical Trials
Cambridge, MA

June 17 - June 20, 2008
BIO International Convention
San Diego, CA

June 22-26, 2008
44th DIA Annual Meeting
Boston, MA

2007

5th Int'l. Congress on Vascular Dementia
November 8th-11th, 2007
Budapest

ASTRO (American Society for Therapeutic Radiology and Oncology
October 28th - Nov 1st, 2007
TBD

ASBMR 29th Annual Meeting
September 16th-19th, 2007
Honolulu, HI

43rd Annual Drug Information Association
June 17th - 21st, 2007
Atlanta, GA

76th European Atherosclerosis Society
June 10th-13th, 2007
Helsinki, Finland

Alzheimer's Association Int'l. Conference on Prevention of Dementia
June 10th-11th, 2007
Washington, DC

43rd ASCO Annual Meeting
June 1st-5th, 2007
Chicago, IL

ACR Annual Meeting and Chapter Leadership Conference
May 19th-24th, 2007
Hilton Washington, WA DC

Bio International Convention
Boston Convention Center Boston, MA
Exhibit Dates: May 7-9, 2007

Accelerating Patient Recruitment & Retention in Clinical Trails
April 16-17, 2007
Central London, United Kingdom

Accelerating Patient Recruitment & Retention in Clinical Trails
April 16-17, 2007
Central London, United Kingdom

6th Annual CNS Clinical Trials Event
April 11th-12th, 2007
Orlando, FL

16th Annual Partnership with CROs and Other Outsourcing Providers
April 10th-12th, 2007
Orlando, FL
Booth #606

19th Annual EuroMeeting
March 26th-28th, 2007
Vienna, Austria
Booth #233-234.

American Academy of Orthopaedic Surgeons
February 14th-18th, 2007
San Diego, CA

ISC (International Stroke Conference)
February 7th-9th, 2007
San Francisco, CA

Annual Partnering with Central Labs, ECG, and Imaging Core
January 17th, 2007
Anaheim, CA - Booth #20

2006

American Heart Association
November 12th – 14th, 2006
Booth #2363
Chicago, IL

Center for Business Intelligence (CBI) - Medical Imaging for Clinical Trials
October 26th – 27th
Tyson’s Corner, VA

31st European Society for Medical Oncology (ESMO)
29th September - 3rd October, 2006
Istanbul Convention & Exhibit Center (ICEC) Istanbul, Turkey

28th American Society for Bone and Mineral Research (ASBMR) Annual Meeting
September 15th – 19th, 2006
Pennsylvania Convention Center
Philadelphia, PA

World Congress of Cardiology
September 2nd - 6th, 2006
Barcelona, Spain

IIR - Imaging in Clinical Trials
July 18th - 19th, 2006
Hyatt Regency, Princeton, NJ

The 10th International Conference on Alzheimer’s Disease and Related Disorders
July 15th – 20th, 2006
Centro De Convenciones – Madrid, Spain

SMI: Clinical Trials in Cancer
June 26th - June 27th, 2006
Holiday Inn Bloomsburry London, UK

Annual European League Agains't Rheumatism (EULAR)
June 21st - 24th, 2006
Amsterdam RAI - Amsterdam, Netherlands

42nd Drug Information Association (DIA) Annual Meeting
June 18th – 22nd, 2006
Pennsylvania Convention Center
Philadelphia, PA
Visit CCBR-Synarc at Booth numbers: 620 & 622

2006 ASCO Annual Meeting
June 2nd – 6th, 2006
Georgia World Congress Center
Atlanta, Georgia

Medical Imaging for Enhanced Clinical Development (Marcus Evans)
May 16th -17th, 2006
Key Bridge Marriott
Arlington, Virginia

SMI’s 2nd Annual Imaging in Oncology conference
March 13th – 14th, 2006
Millennium Gloucester Hotel, London, United Kingdom

55th Annual Scientific Session of the American College of Cardiology (ACC.06)
March 11th - 14th, 2006
Georgia World Congress Center
Atlanta, GA
Visit CCBR-Synarc at Booth number: 2717

Developing Imaging Biomarkers in Drug Discovery & Development
“Conducting successful implementation and evaluation of imaging informatics”
Dr. Klaus Engelke, Director of Special Imaging Technique at CCBR-Synarc will lead a workshop on Monday, January 23rd.
January 23rd – 25th
Danubius Regents Park Hotel
London, UK

4th Annual Partnering with Central Labs, ECG, and Imaging Labs Conference
January 18th – 20th
Sheraton Palace Hotel
San Francisco, CA

2005

American Heart Association (AHA)
November 13th – 16th
Dallas Convention Center, Dallas, TX
Visit CCBR-Synarc at Booth Number: 3109

Center for Business Intelligence: 3rd Annual Medical Imaging for Clinical Trials
October 27 – 28, 2005
Alexandria, VA

27th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR)
September 23rd – 27th
Gaylord Opryland Resort and Convention Center
Nashville, Tennessee
Visit CCBR-Synarc at Booth Number: 102 & 104

European Society of Cardiology (ESC)
September 3rd – 7th
Stockholm International Fairs
Visit CCBR-Synarc at Booth Number: C08:00

Drug Information Association
June 26th – 29th
Washington Convention Center
Washington, D.C.
Visit CCBR-Synarc at Booth Number: 1037 & 1039

Alzheimer’s Association International Conference on Prevention of Dementia: Early Diagnosis and intervention
June 18th – 21st
Marriott Wardman Park Hotel, Washington, D.C.

European League Agains’t Rheumatism (EULAR)
June 8th – 11th
Austria Center Vienna, Vienna, Austria

American Society of Clinical Oncology (ASCO)
May 13th – May 17th
Orange County Convention Center, Orlando FL

Partnerships with CROs
April 4th – 6th
Adam’s Mark Hotel, Dallas, TX

2004

American College of Rheumatology (ACR) 68th Annual Meeting
16 - 21 October 2004
Henry B. Gonzalez Convention Center, San Antonio, TX US
Visit CCBR-Synarc Booth #1625 & 1627

Sessions of Interest:

• The Role of MRI in RA
  - Charles G. Peterfy, M.D., Ph.D.
• Novel Imaging Approaches to Study Cartilage
  - Charles G. Peterfy, M.D., Ph.D.

CBI's Medical Imaging for Clinical Trials
28 - 29 October 2004
Philadelphia, PA USA

Sessions of Interest:

• Track B - Osteoarthritis/Rheumatoid Arthritis, "Maximize Imaging Endpoints for Rheumatoid Arthritis Clinical Trials, New Challenges of Structure, Modifying Therapies for RA"
  - Charles G. Peterfy, M.D., Ph.D.

International Skeletal Society 31st Annual Refresher Course Diagnosis and Management of Skeletal Disorders
6 - 9 October 2004
Westin Dragonara Resort MALTA

Sessions of Interest:

• Spine Update
  - Harry K. Genant, M.D.
• Special Focus Session 8A, Advances in Technology: Micro MR and CT in Bone Diseases
  - Harry K. Genant, M.D.
• Is MR Valuable for Monitoring Drug Treatment of Cartilage?
  - Charles G. Peterfy, M.D., Ph.D.

American Society of Bone and Mineral Resources (ASBMR) 26th Annual Meeting
1 - 5 October 2004
Seattle, WA USA
Visit CCBR-Synarc Booth #405 & 407

UKICRS/BPC 2004 - 'Imaging From Molecules to Man'
28 September 2004
Manchester UK

Session of Interests:

• Targeting Tumor Blood Vessels: Perfusion MRI in Phase I Trials
  - Anwar R. Padhani, M.D., Ph.D.

Functional Imaging in Oncology
24 September 2004
Nimegen, THE NETHERLANDS

Session of Interests:

• Targeting Tumor Blood Vessels: Perfusion MRI in Phase I Trials
  - Anwar R. Padhani, M.D., Ph.D.

European Society of Uroradiology
9 - 12 September 2004
Santiago de Compostla SPAIN

Session of Interests:

• Imaging Angiogenesis with CT/MRI
  - Anwar R. Padhani, M.D., Ph.D.

European Society of Cardiology
28 August - 2 September 2004
Munich GERMANY
Visit CCBR-Synarc Booth #B1-10450

9th International Conference on Alzheimer's Disease and Related Disorders
17 - 22 July 2004
Pennsylvania Convention Center
Philadelphia, PA USA
Visit Us at Booth #300

23rd International Congress of Radiology and the ISR
25 - 29 June 2004
Palais des Congres de Montreal
Montréal, Québec CANADA

Sessions of Interest:

• Joint Session MR/GU: Prostate - Functional MRI Application
  25 June 2004. Anwar Padhani
   
• Magnetic Resonance Imaging (MRI) Track: MR IN CANCER
  26 June 2004. Moderators: Anwar Padhani, United Kingdom & Caroline Reinhold, Canada
   
• Functional Imaging Assessment of Tumour Response
  Anwar Padhani

EUROPEAN SOCIETY OF MUSCULOSKELETAL RADIOLOGY (ESSR) 11th Annual Meeting
18 - 19 June 2004
Augsburg GERMANY

Refresher Course:

• Postgraduate Special Focus Session: Vertebroplasty in the Osteoporotic Patient (June 18th)
  
  Chairpersons: Giuseppe Guglielmi / Harry Genant

Drug Information Association (DIA) 40th Annual Meeting
13 - 16 June 2004
Washington Convention Center
Washington, DC USA

Visit Us at Booth 625 & 626

American Society of Clinical Oncology (ASCO)
40th Annual Meeting
5 - 8 June 2004
Ernest N. Morial Convention Center
New Orleans, LA USA

Visit Us at Booth #1620

European Calcified Tissue Symposium
5-7 June 2004
Nice, FRANCE

Sessions of Interest:

• Training course: Osteoporosis: Prediction of Fracture
  5 June 2004. Patrick Garnero
• Training Course: How to Use Bone Turnover Markers in a Multicentre Trial?
  5 June 2004. Patrick Garnero
• Invited lecture: New Markers of Bone Turnover
  6 June 2004. Patrick Garnero
• Plenary Session: Osteoporosis and Fracture.
  6 June 2004. Chairman: Patrick Garnero

Lecture of Interest:

• The Thermo Electron Clinical Chemistry and Automation Systems Award: New developments in biochemical markers of bone turnover and their clinical application
  20 May 2004, Dr. Patrick Garnero

Workshop:

• Imaging In Arthritis
  Workshop Leader: Charles G. Peterfy

CBI's Medical Imaging in Oncology
22 - 23 April 2004
Hilton San Diego Mission Valley Hotel
San Diego, CA USA

Educational Sponsor:  CCBR-Synarc, Inc.

Workshop of Interest:

• "WHY, WHEN AND HOW TO IMAGE"
  22 April 2004.  Michele Britton; Manish Kothari, Ph.D.; Ted Gastineau; and Ali Guermazi, M.D.

Download the complete conference brochure

SMI's Imaging in Oncology
17 - 18 March 2004
The Hatton
London UK

Sessions of Interest:

• "TARGETING TUMOR BLOOD VESSELS, The Role of MRI"
  18 March 2004, Dr. Anwar Padhani
   
• "INDEPENDENT ASSESSMENT OF TUMOR RESPONSE IN NON-HODGKIN'S LYMPHOMAS, Role of Imaging"
  18 March 2004, Dr. Yves Miaux

European Congress of Radiology (ECR)
5 - 9 March 2004
Vienna AUSTRIA

Abstract, Presentation and Poster of Interest:

• MRI of tumour angiogenesis

SPIE International Symposium
Medical Imaging 2004
14 - 19 February 2004
San Diego, CA USA

Workshop of Interest:

• "Medical Imaging for Clinical Trials: Imaging Processing", 17 February

Presenters/Panelists: Mostafa Analoui, Pfizer Global Research and Development; Charles Peterfy, CCBR-Synarc; Lawrence Schwartz, Memorial Sloan-Kettering Cancer Center; Chun, Yuan, University of Washington

2003

Radiological Society of North America
89th Scientific Assembly and Annual Meeting
30 November - 5 December 2003
McCormick Place
Chicago, Illinois USA

Abstracts and Posters of Interest:

• Bone erosions in rheumatoid arthritis: which imaging modality is the most useful?
  --Ali Guermazi, Bachir Taouli, Yves Miaux, Charles G. Peterfy (Poster)
• Neuroradiological Findings in Vascular Dementia.
  --Ali Guermazi, Yves Miaux, Martine Sieffert, Stephen Salloway, Harvey Altman, Raymond Pratt (Poster)

American College of Rheumatology (ACR)
ACR/ARHP 67th Annual Scientific Meeting
Orange Convention Center
23 – 28 October 2003
Orlando, Florida USA
Visit Us on Booth #1210

Scientific Abstracts, Presentations, Posters and Sessions of Interest:

• ACR Mini-Symposium: Advances in imaging of joint structure.

Moderator:  Charles G. Peterfy

·         Serum RANK-ligand Modifies the effect of Disease Activity on Radiographic Progression. Robert B. M. Landewé¹, Piet Geusens¹, Maarten Boers², Patrick Garnero³, Désirée van der Heijde¹, Sjef van der Linden¹. ¹University Hospital Maastricht, Maastricht, Netherlands; ²Free University Medical Center, Amsterdam, Netherlands; ³CCBR-Synarc & INSERM, Lyon, France.

·         Serum levels of Receptor Activator of Nuclear Factor Kappa-Beta (RANK)-ligand (L) and Osteoprotegerin (OPG) Independently Predict Long-term Radiographic Progression in Patients with Early Rheumatoid Arthritis (RA).  Piet Geusens¹, Maarten Boers², Désirée van der Heijde¹, Sjef van der Linden¹, Patrick Garnero³, Robert Landewé¹. ¹University Hospital Maastricht, Maastricht, Netherlands; ²Free University Medical Center, Amsterdam, Netherlands; ³CCBR-Synarc & INSERM, Lyon, France.

·         Association of 10 Biochemical markers of Bone, Cartilage and Synovium with Disease Activity and Joint Damage in Hip Osteoarthritis Patients: the ECHODIAH Cohort.  P. Garnero¹, B. Maziéres², A. Gueguen³, M. Abbal², L. Berdah⁴, C. Freiburghaus⁵, M. Lequesne⁶, M. Nguyen⁷, J. P. Salles², E. Vignon⁸, M. Dougados⁷. ¹CCBR-Synarc, Lyon, France; ²Univ. Sabatier, Toulouse, France; ³Inserm, Paris, France; ⁴Laboratoires Negma, Toussus le Noble, France; ⁵Anamar, Lund, Sweden; ⁶Hosp. Bellan, Paris, France; ⁷Hosp. Cochin, Paris, France; ⁸Hosp. Lyon Sud, Lyon, France.

·         Teriparatide-Induced Reduction in the Incidence of Back Pain Persists at Least 18 Months After Therapy Discontinuation. John H. Krege¹, Wim H. Scheele¹, Li Xie¹, Harry K. Genant². ¹Eli Lilly and Company, Indianapolis, IN; ²UCSF, San Francisco, CA

·         Biochemical markers of Cartilage Breakdown and Synovitis are Strong Independent Predictors of Structural Progression of Hip Osteoarthritis (OA). The ECHODIAH cohort.  B. Mazieres¹, P. Garnero², A. Gueguen³, M. Abbal¹, L. Berdah⁴, C. Freiburghaus⁵, M. Lequesne⁶, M. Nguyen⁷, J. Salles¹, E. Vignon⁸, M. Dougados⁷. ¹Rangueil hospital, Toulouse, France; ²CCBR-Synarc, Lyon, France; ³Inserm U88, Paris, France; ⁴Negma-Lerads, Paris, France; ⁵AnaMar, Lund, Sweden; ⁶Belan hospital, Paris, France; ⁷Cochin hospital, Paris, France; ⁸South hospital, Lyon, France

·         p38α MAP Kinase Inhibition Improves Clinical Scores and Blocks Cartilage and Bone Destruction in Early and Advanced Stages of Murine Collagen Type II Arthritis. Satyanarayana Medicherla¹, Jing Y Ma¹, Ruban Mengadu¹, Yebin Yang², Jenny Zhao², Jit Chakravarty¹, Sundeep Dugar¹, Harry Genant², Andrew A. Protter¹. ¹Scios, Sunnyvale, CA; ²University of California, San Francisco, CA

2003 International Osteoporosis Conference (IOC)
Beijing International Hotel
19 - 23 October 2003
Beijing CHINA

DXA Quality Assurance Workshop Sponsor

OARSI World Congress on Osteoarthritis
Palais Am Funkturm
12 - 15 October 2003
Berlin GERMANY

Scientific Poster and Session of Interest:

• Session 9:  Biomarkers and imaging

Chair: Charles G. Peterfy, M.D., Ph.D. and Jean-Yves Reginster, MD, PhD

• Precision and sensitivity to change  of computer-based measurement of joint space width in finger, wrist and toe joints.

G von Ingersleben and J. T. Sharp.

International Conference on Osteoporosis and Bone Research (ICOBR) 2003
Beijing International Convention Center
10 - 14 October 2003
Beijing CHINA

Scientific Poster of Interest:

·         Morphometric vertebral level-specific Critera improve diagnostic accuracy in detection of prevalent vertebral fractures.  C.Wu, T. Fuerst, G. von Ingersleben, S Pourfathi, Y. Miaux. CCBR-Synarc, Inc. San Francisco, USA.

ECCO 12, European Cancer Conference
21 - 25 September 2003
Copenhagen DENMARK

Visit Us on Booth #H-013 (East Hall)

American Society for Bone and Mineral Research (ASBMR)
25th Annual Meeting
19 - 23 September 2003
Minneapolis Convention Center,
Minneapolis, Minnesota USA

Visit Us on Booth #411 & 508

European Society of Neuroradiology (ESNR)
28th Congress
11 - 14 September 2003
Istanbul TURKEY

Abstracts, Posters and Presentations of Interest:

• Neuroradiological Features Associated with Vascular Dementia
  --Yves Miaux, Ali Guermazi, Stephen Salloway, Martine Sieffert, Harvey Altman, Raymond Pratt
• Dural tail sign - How specific it is?
  --Ali Guermazi, Yves Miaux, Francois Laffite, Jean-Francois Bonneville, Jacques Chiras

Annual European Congress of Rheumatology Meeting (EULAR 2003)
18 - 21 June 2003
Lisbon PORTUGAL

Scientific Presentations of Interest:

• IMAGING IN OSTEOARTHRITIS: MRI What Can it Tell us About OA? How Should It Be Used?
  --Charles Peterfy, M.D., Ph.D.
• Biomarkers in the evaluation of the progression of osteoarthritis.
  --Patrick Garnero, PhD

DIA 39th Annual Meeting
15 – 19 June 2003
Henry B. Gonzalez Convention Center
San Antonio, Texas USA

Visit us at Booth #454 & 456

European Society of Musculoskeletal Radiology 10th Annual Meeting
13 – 14 June 2003
Aarhus DENMARK

Abstracts, Lectures, Posters and Presentations of Interest:

• MRI of peripheral joint arthritis with emphasis on subchondral bone and cartilage
  --Charles G. Peterfy, M.D., Ph.D.
• Osteoporosis in inflammatory disorders
  --Harry K. Genant, M.D.

American Society of Clinical Oncology (ASCO)
39th Annual Meeting
30 May - 3 June 2003
McCormick Place
Chicago, Illinois USA

Education Grant Sponsor
Visit us at Booth #1428

DIA Medical Imaging In Clinical Trials
7 – 8 April 2003
Boston Marriott Long Wharf, Boston, MA, USA

Presentations of Interests:

• GETTING THE WORK DONE, PRACTICAL ISSUES: CFR(11) Compliance in Customized Analyses
  --Manish Kothari, Ph.D.
  
  
• OSTEOARTHRITIS IMAGING, IMAGING STRUCTURAL CHANGES IN OSTEOARTHRITIS: Assessing the Joint as a Whole-Organ?
  --Charles G. Peterfy, M.D., Ph.D.

2002

American College of Rheumatology (ACR) 65th Annual Scientific Meeting
New Orleans, LA. USA
24- 29 October 2002

Abstracts and Posters of Interest:

• MRI Findings Associated with Knee Pain: Analysis of Discordant Knee Pairs in Health ABC.

  K S Wildy1, M C Nevitt2, C K Kwoh1, N Lane2, S Krishnaswami1, C G Peterfy3, S Kritchevsky4, T Harris5, S Zaim3, A Guermazi2, D Felson6, A B Newman1.1University of Pittsburgh, Pittsburgh, PA;2UCSF, San Francisco, CA;3CCBR-Synarc, Inc., San Francisco, CA; 4University of Memphis, Memphis, TN;5NIH, Bethesda, MD;6Boston University, Boston, MA.
  Presentation Number: 306
  

• Prevalence and Correlates of Knee Cartilage Defects, Meniscal Lesions and Other Abnormalities Evaluated by MRI in a Population Sample of Knees with Normal X-rays: The Health ABC Study.

  Bachir Taouli1, Ali Guermazi1, Souhil Zaim2, Charles G Peterfy2, Andreas Mohr1, David Felson3, Kathryn Wildy4, Benjamin W E Wang5, John A Lynch1, Tamara Harris6, Bo Fan1, Nancy E Lane1, Harry K Genant1, Michael C Nevitt1.1UCSF, San Francisco, CA;2CCBR-Synarc, Inc., San Francisco, CA;3Boston University, Boston, MA;4University of Pittsburgh, Pittsburgh, PA;5University of Tennessee, Memphis, TN;6NIA, Bethesda, MD.
  Presentation Number: 307
   

• Relationships between Spinal Osteoarthritis, Vertebral Fractures and Bone Mass. The Rancho Bernardo Study.

  Mikayel Grigorian1, Diane L Schneider2, Bo Fan1, Anke L Fierlinger3, Julie C Sandwell2, Harry K Genant1, Elizabeth Barrett-Connor2
  1University of California San Francisco, San Francisco, CA;2University of California San Diego, San Diego, CA, 3CCBR-Synarc, Inc., San Francisco, CA.
  Presentation Number: 298
   

• Inflammation is Closely Related with Cartilage Degradation: A Longitudinal Analysis of Esr, Das28 and Cartilage Degradation Products (ctx-ii) in the Cobra Trial.

  Robert B M Landewé1, Piet Geusens1, Maarten Boers2, Désirée M F van der Heijde3, Patrick Garnero4. 1University Hospital Maastricht, Maastricht, Netherlands2Free University Medical Center Amsterdam, Amsterdam, Netherlands3University Hospital, Maastricht, Netherlands,4INSERM and CCBR-Synarc, Lyon, France
  Presentation Number: 581
  

• Inflammation Markers (CRP, TNF-a, IL-6) are not Associated with Radiographic or MRI Findings of Knee OA in the Elderly: The Health ABC Study.

  Michael Nevitt1, David Felson2, Charles Peterfy3, Kathryn Wildy4, Shari Ling5, Nancy Lane1, Anne Newman4, Laura Carbone6, Tamara Harris7.1UCSF, San Francisco, CA;2Boston University, Boston, MA;3CCBR-Synarc, Inc., San Francisco, CA;4U. Pittsburgh, Pittsburgh, PA;5University of Tennessee, Memphis, TN;6U. Tennessee, Memphis, TN;7NIA, Bethesda, MD.
  Presentation Number: 962
   

• Short-Term Reduction in Urinary CTX-II, a Marker of Cartilage Degradation, Predicts Long-Term Radiological Progression in Patients with Rheumatoid Arthritis (RA) Treated with Disease-Modifying Antirheumatic Therapy (DMARD).

  Patrick Garnero1, R B M Landewé2, M Boers3, S Christgau3, S J van der Linden3, D van der Heijde3, P Geusens4. 1CCBR-Synarc and Inserm Unit 403, Lyon, France; 2University Hospital Maastricht, Maastricht, Netherlands; 3Nordic Bioscience Diagnostics, Herlev, Denmark; 4Willems Institut, Diepenbeek, Belgium.
  Presentation Number: 971
  

• Receptor Activator of the Nuclear Factor Kappa-B Ligand (RANKL) in the Serum of Patients with RA is Strongly Coupled to Rheumatoid-Factor Presence, and Predicts Long-Term Radiologic Progression.

  Piet Geusens1, Robert Landewé2, D Chen3, Colin Dunstan3, Patrick Garnero4, Sjef van der Linden2, Maarten Boers5.1Limburg University Center & University Hospital, Diepenbeek/Maastricht, Belgium; 2University Hospital, Maastricht, Netherlands; 3Amgen, Thousands Oaks, CA; 4CCBR-Synarc and Inserm, Lyon, France; 5VU University Hospital, Amsterdam, Netherlands.
  Presentation Number: 1003
   

• MRI in Rheumatoid Arthritis at OMERACT 2002: Suggested "Core Set" of MRI Acquisitions, Definitions of Important Joint Pathologies, and Scoring System (OMERACT 2002 RAMRIS).

  Mikkel Ostergaard1, Fiona McQueen2, Charles Peterfy6, Philip Conaghan4, Marissa Lassere5, Paul Bird5, Bo Ejbjerg1, Ron Shnier5, Phil O'Connor4, Mette Klarlund1, Paul Emery4, Harry Genant3, John Edmonds5.1Hvidovre University Hospital, Copenhagen, Denmark; 2Auckland Hospital, Auckland, New Zealand; 3UCSF, San Francisco, CA; 4Leeds General Infirmary, Leeds, United Kingdom; 5St George Hospital, Sydney, Australia; 6CCBR-Synarc, Inc., San Francisco, CA.
  Presentation Number: 1407
   

• Reliability of Automated Measurement of Radiographic Knee Joint Space Width (JSW) Using Semi-flexed, Posterior-anterior (P-A) Technique and a Standard Positioning Device in a Rural, Community Setting. Category: 29 Epidemiology.

  Joanne M Jordan1, Jordan B Renner1, John A Lynch2, Ali Guermazi2, Jeffrey Duryea3, Charles Peterfy4, Sarah Williams1, Gheorghe Luta1, Harry Genant2. 1University of North Carolina, Chapel Hill, NC;2University of California San Francisco, San Francisco, CA;3Harvard University, Boston, MA;4CCBR-Synarc, Inc., San Francisco, CA.
  Presentation Number: 1242

Presentations of Interest:

• Prevalence of Meniscus and Ligament Tears and Their Correlation with Cartilage Morphology and Other MRI Features in Knee Osteoarthritis (OA) in the Elderly: The Health ABC Study.

  Ali Guermazi1, Bachir Taouli1, John A Lynch1, Jing Li1, Charles G Peterfy2, Kathryn Wildy3, Steve Kritchevsky4, Yan Chen1, Tamara Harris5, Nancy E Lane1, Harry K Genant1, Michael C Nevitt1.1University of California San Francisco, San Francisco, CA;2CCBR-Synarc, Inc., San Francisco, CA;3University of Pittsburgh, Pittsburgh, PA;4University of Tennessee, Memphis, TN;5NIH, Bethesda, MD.
  Presentation Number: 1522
   

• Reproducibility of Semiflexed (MTP) Radiography for OA Knees in a Multicentre Clinical Trial.

  C Buckland-Wright1, R Ward1, C Mojcik2, T Taylor2, C Peterfy3, D Lissin3, R Leff2 1King'S College, London, United Kingdom2Bayer, New Haven, CT;3CCBR-Synarc Inc., San Francisco, CA.
  Presentation Number: 1523

24th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR)
San Antonio, Texas, USA.
20 - 24 September 2002

Abstracts and Posters of Interest:

• Reduction in Bone Turnover Predicts Hip, Non-spine, and Vertebral Fracture in Alendronate Treated Women: The Fracture Intervention Trial.

  D. C. Bauer1, D. M. Black1, P. Garnero2, M. Hochberg3, S. Ott4, D. L. Schneider5, J. Orloff6, D. Thompson6, S. Ewing*1, P. D. Delmas2. 1University of California, San Francisco, San Francisco, CA, USA, 2INSERM, Lyon, France, 3University of Maryland, Baltimore, MD, USA, 4University of Washington, Seattle, WA, USA, 5University of California, San Diego, San Diego, CA, USA, 6Merck, Rahway, NJ, USA.
  Presentation Number: SA106
  

• Receptor Activator of the Nuclear Factor Kappa-B Ligand (RANKL) in Serum Is Related to Bone Density, Cartilage Breakdown and Inflammation in Early Active Rheumatoid Arthritis.

  P. Geusens1, R. Landewé*2, D. Chen*3, C. Dunstan*3, P. Garnero4, S. van der Linden*2, M. Boers*5. 1Rheumatology, Maastricht University, Maastricht, Netherlands; 2Maastricht University, Maastricht, Netherlands, 3Amgen, Thousands Oaks, CA, USA; 4INSERM, Lyon, France, 5VU University Hospital, Amsterdam, Netherlands.
  Presentation Number: SU417
  

• Long-term Variability of Markers of Bone Turnover in Postmenopausal Women and Implications for their Clinical Utility. The OFELY Study.
  

  P. Garnero1, D. Mulmann*2, F. Munoz*3, E. Sornay-Rendu*3, P. D. Delmas3. 1CCBR-Synarc, Inserm Unit 403, Lyon, France; 2INSERM unit 403, Lyon, France; 3Inserm Unit 403, Lyon, France.
  Presentation Number: SU023

• Evaluation of a Fully Automated Assay for Serum Procollagen Type I N-propeptide in Osteoporosis.

  P. Garnero1, P. D. Delmas2. 1CCBR-Synarc, Inserm Unit 403, Lyon, France; 2Inserm Unit 403, Lyon, France.
  Presentation Number: SU101
  

• Body Composition and Serum Leptin Changes during Hormone Replacement Therapy: A Prospective Study.

  A. Arabi*1, C. Roux1, R. Porcher*2, C. L. Benhamou3, P. Garnero4. 1Rhumatologie, Hôpital Cochin, Paris, France; 2Hôpital Saint Louis, Paris, France; 3ERIT M0101, Orleans, France; 4CCBR-Synarc, INSERM U403, Lyon, France.
  Presentation Number: SU31

  Presentations of Interest:

• Increased Risk of Falls, Increased Bone Resorption and Decreased Bone Mineral Density in Elderly Men with Hypogonadism. The MINOS Study Presentation.

  P. Szulc1, F. Munoz*1, B. Claustrat*2, P. Garnero1, F. Marchand*3, P. D. Delmas1. 1INSERM 403 Research Unit, Lyon, France; 2Hôpital Cardiologique, Lyon, France; 3SSMB, Montceau les Mines, France.
  Presentation Number: 1209